Literature DB >> 728907

Role of interferon in augmentation of natural and antibody-dependent cell-mediated cytotoxicity.

R B Herberman, J Y Djeu, J R Ortaldo, H T Holden, W H West, G D Bonnard.   

Abstract

Natural killer (NK) activity in rats and NK and antibody-dependent cell-mediated cytotoxicity in mice have been shown to be rapidly augmented by in vivo treatment with a variety of viruses and immune adjuvants. Poly I:C and other interferon inducers also caused boosting in NK-cell activity, with peak levels occurring at about the time of peak interferon levels. Crude and purified virus-induced interferon itself had strong boosting effects in mice, both when inoculated in vivo and when incubated briefly with normal spleen cells. The in vitro activation by interferon or by poly I:C was completely abrogated by anti-interferon. Interferon also appears to play a central role in augmentation of human NK-cell activity. Inoculation of normal volunteers with influenza virus or of a patient with poly I:C produced rapid boosting. In vitro incubation of peripheral blood mononuclear cells with various interferon preparations for 1 hour or overnight usually produced an appreciable increase in lytic activity.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 728907

Source DB:  PubMed          Journal:  Cancer Treat Rep        ISSN: 0361-5960


  9 in total

1.  Effect of recombinant gamma interferon on natural killer cell activity in patients with gastric cancer.

Authors:  Y Kuwahara; K Kusugami; K Morise; K Shimokata
Journal:  Gastroenterol Jpn       Date:  1987-08

Review 2.  Interferons and their stimulated genes in the tumor microenvironment.

Authors:  Hyeonjoo Cheon; Ernest C Borden; George R Stark
Journal:  Semin Oncol       Date:  2014-02-14       Impact factor: 4.929

3.  Treatment of a patient with malignant mesothelioma with interferon-alpha 2 based on in vitro sensitivity tests.

Authors:  V Sexl; L Wagner; M Wiesholzer; E Presterl; W Base
Journal:  Clin Investig       Date:  1994-03

Review 4.  Swainsonine: a new antineoplastic immunomodulator.

Authors:  S Mohla; M J Humphries; S L White; K Matsumoto; S A Newton; C C Sampson; D Bowen; K Olden
Journal:  J Natl Med Assoc       Date:  1989-10       Impact factor: 1.798

5.  Preventive effects of OK432 on murine acute myocarditis due to encephalomyocarditis virus.

Authors:  T Yokoyama; T Kanda; T Suzuki; K Murata
Journal:  Cardiovasc Drugs Ther       Date:  1991-04       Impact factor: 3.727

6.  Evaluation of the human interferon system in viral disease.

Authors:  S Levin; T Hahn
Journal:  Clin Exp Immunol       Date:  1981-12       Impact factor: 4.330

7.  Antiviral activity of bacteria-derived human alpha interferons against encephalomyocarditis virus infection of mice.

Authors:  P K Weck; E Rinderknecht; D A Estell; N Stebbing
Journal:  Infect Immun       Date:  1982-02       Impact factor: 3.441

8.  The effect of recombinant alpha-interferon on natural killer cell activity and clinical course in patients with myelodysplastic syndrome.

Authors:  X Yataganas; G Eliopoulos; S Koulocheri; N Viniou; E Plata; P Panagiotidis; G Vayopoulos; J Meletis; P Fessas
Journal:  Ann Hematol       Date:  1991-06       Impact factor: 3.673

9.  Characterization of ductal carcinoma in situ cell lines established from breast tumor of a Singapore Chinese patient.

Authors:  Jacklyn Wy Yong; Meng Ling Choong; SiFang Wang; Yu Wang; Shermaine Qy Lim; May Ann Lee
Journal:  Cancer Cell Int       Date:  2014-09-20       Impact factor: 5.722

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.